7 Best Hemp Stocks To Buy Now
On April 30, Reuters reported that after the U.S. rescheduled loosened restrictions, firms developing cannabis-based drugs are planning for initial public offerings and private financing.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,067,632 | $2,444,877 | +13% | 0% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 547,234 | $1,253,166 | +141% | 0% |
| 3. | Millennium Management Israel Englander | 361,142 | $826,849 | -68% | 0% |
| 4. | Walleye Capital Will England | 310,915 | $711,995 | -63% | 0% |
| 5. | Point72 Asset Management Steve Cohen | 242,558 | $555,449 | +2% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,714,926 | $3,927,181 | 0.01% | |
| 2. | 1,328,774 | $3,042,892 | 0.55% | |
| 3. | 395,300 | $905,237 | 0% | |
| 4. | 340,132 | $778,902 | 0% | |
| 5. | 257,106 | $585,994 | 0% |